Alveolar Rhabdomyosarcoma treatment in India at an efficient cost

Published: 09th June 2010
Views: N/A

Treatment of Alveolar Rhabdomyosarcoma in India is done under best medical supervision. India is becoming the leading destination for rhabdomyosarcoma treatment because of the availability of most advanced surgical techniques for the treatment. In India you will find many destinations where you can avail benefits of Medical Tourism, with Kerala, Goa and Delhi being the pioneer in the field. The Country offers affordable and best medical treatments to medical tourists. These treatments are offered by highly specialized hospitals in India. Treatment of Alveolar Rhabdomyosarcoma in India is done at an affordable cost, which is beneficial for international patients.

What is Alveolar Rhabdomyosarcoma?

Alveolar Rhabdomyosarcoma is a fast-growing, highly malignant tumor which accounts for over half of the soft tissue sarcomas in children. Less frequently, other soft tissue sarcomas are found in children: fibro sarcoma, mesenchymoma, synovial sarcoma, and liposarcoma. Alveolar Rhabdomyosarcoma often causes a noticeable lump on a child's body. If the tumor is located internally, the symptoms depend on its location. For example, tumors in the nasal passage may put pressure on the eustachian tubes; a bladder tumor can cause trouble urinating; an orbital tumor may cause the eye to protrude.

Alveolar Rhabdomyosarcoma tumors arise from a cell called a "rhabdomyoblast", which is a primitive muscle cell. Instead of differentiating into striated muscle cells, the rhabdomyoblasts grow out of control. Since this type of muscle is located throughout the body, the tumors can appear at numerous locations. The four major sites in which rhabdomyosarcoma found are:

• head and neck; around the eyes -- 35-40%

• genitourinary tract -- 20%

• extremities -- 15-20%

• trunk (chest and lungs) -- 10-15%

Depending on the "histology" of the cells (how they look under a microscope), the tumors are classified as one of the following:

Embryonal Alveolar Rhabdomyosarcoma: Most common type, usually found in children under 15 and in the head and neck region and genitourinary tract.

Botryoid type: A variant of the embryonal type; the tumor arises as a grape-like lesion in mucosal-lined hollow organs such as the vagina and urinary bladder.Alveolar type: A more aggressive tumor which usually involves the muscles of the extremities or trunk.

Pleomorphic type: Usually seen in adults and arises in muscles of the extremities.

Causes of Alveolar Rhabdomyosarcoma

The cause of Alveolar Rhabdomyosarcoma is unknown. It is a rare tumor with only several hundred new cases per year throughout the United States. Some children with certain birth defects are at increased risk, and some families have a gene mutation that elevates risk. However, the vast majority of children with Alveolar Rhabdomyosarcoma do not have any known risk factors.

Symptoms of Alveolar Rhabdomyosarcoma

Symptoms of Alveolar Rhabdomyosarcoma vary depending on location of the tumor. Tumors in the nose or throat may cause bleeding, congestion, swallowing problems, or neurological problems if they extend into the brain. Tumors in the vagina may be visibly protruding from the opening of the vagina. Bladder and vaginal tumors may cause urinary or bowel obstruction. Tumors in the muscles may appear as a painful lump and are often thought to be an injury. However, they do not go away, but continue to grow, even though they may not continue to be painful.

Diagnosis of Alveolar Rhabdomyosarcoma is often delayed because of lack of symptoms, and because the tumor may appear at the same time as a recent injury. Early diagnosis is important because Alveolar Rhabdomyosarcoma is an aggressive tumor that spreads quickly.

Treatment of Alveolar Rhabdomyosarcoma

Alveolar Rhabdomyosarcoma can be treated with chemotherapy, surgery and/or radiation. Often a combination of these treatments offers the best chance of success. Rhabdomyosarcoma treatment at Mayo Clinic has two main goals: (1) to cure the cancer and (2) to save as much function of the affected area as possible.


Surgeons will remove the tumor if safe to do so. Chemotherapy and radiation may be given before or after surgery to kill any cancer cells. Surgeons will remove the tumor if removal does not cause disability or disfigurement.


A combination of cancer-fighting drugs attacks rhabdomyosarcoma cells wherever they may be in the body. If a patient receives chemotherapy and surgery, the timing of each is closely coordinated.


Radiation oncologists apply high-energy external beam radiation to tissues containing Alveolar Rhabdomyosarcoma cells. Radiation may be used to supplement surgery, before or afterward, or for cases when the tumor cannot be safely removed. Depending upon the tumor's size, shape and location, treatment involves the use of 3-D conformal radiation therapy or intensity-modulated radiation therapy, both highly precise technologies.

The cure rate for Alveolar Rhabdomyosarcoma depends on many factors, including:

• Age of the patient

• Exact type of tumor

• Tumor's location in the body

• The size of the tumor at diagnosis

• Whether the cancer has spread (metastasized)

Why India?

India has tens of thousands of skilled physicians and nurse practitioners for the treatment of Alveolar Rhabdomyosarcoma. Over the last two decades, the economic boom in India has led to the building of medical facilities & infrastructure that rival the very best that western medical care in the west has to offer. Many of the physicians that practice in these hospitals and clinics have returned (to India) from the U.S. and Europe, leaving behind successful practices. While some small countries may be viable as alternatives for minor surgical procedures, India is the only mainstream option that offers a comprehensive solution for any and all medical needs and does this with the highest levels of service, facilities and professional skills. For more information about Alveolar Rhabdomyosarcoma in India, visit us at or mail your queries at or call us at: +91-9371136499, +91- 9860755000 (International) / + 1-415-599-2537 (USA) / +44-20-8133-2571 (UK).

Report this article Ask About This Article

More to Explore